Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 076418
Company: MYLAN
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
AMLODIPINE BESYLATE AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET;ORAL Discontinued None No No
AMLODIPINE BESYLATE AMLODIPINE BESYLATE EQ 5MG BASE TABLET;ORAL Discontinued None No No
AMLODIPINE BESYLATE AMLODIPINE BESYLATE EQ 10MG BASE TABLET;ORAL Discontinued None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
10/03/2005 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
04/03/2018 SUPPL-20 Labeling-Package Insert, Labeling-Patient Package Insert

Label is not available on this site.

09/25/2015 SUPPL-17 Labeling-Package Insert

Label is not available on this site.

09/21/2014 SUPPL-16 Labeling-Patient Package Insert, Labeling-Package Insert

Label is not available on this site.

03/22/2011 SUPPL-12 Labeling-Package Insert

Label is not available on this site.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English